About
George Gayed is co-founder at Ranvier and holds a PharmD degree with RAC-Drugs certification. He has over five years of clinical experience and more than two years in regulatory affairs leadership roles, with expertise spanning IND, NDA, and BLA submissions, FDA communications, and drug product labeling. His background includes a postdoctoral fellowship in regulatory affairs strategy at Sumitomo Pharma America and specialized training in drug development.
Experience
- RanvierCo-Foundercurrent2025 — present
- Kite PharmaManager, Regulatory Affairscurrent2024 — present
- Intelligence VenturesAssociatecurrent2023 — present
- Catalyst Pharmaceuticals, Inc.Manager, Regulatory Affairs2024
- Sumitomo Pharma AmericaPost-Doctoral Fellow, Regulatory Affairs2022 — 2024Cambridge, Massachusetts, United States
- Massachusetts College of Pharmacy and Health SciencesAdjunct Faculty2022 — 2024
Education
- VCU School of PharmacyDoctor of Pharmacy - PharmD
- Virginia Commonwealth UniversityBachelor of Science - BS, Chemistry
Skills & more
Regulatory GuidelinesOrphan DrugsRegulatory FilingsMedical WritingDocument PreparationCommon Technical Document (CTD)Protocol DevelopmentContract Research Organization (CRO)Investigator BrochuresICHAnalytical SkillsMicrosoft Office
+12 more
NegotiationPresentation SkillsRegulatory StrategyStandard Operating Procedure (SOP)PharmaceuticsLeadershipGood Manufacturing Practice (GMP)Good Clinical Practice (GCP)BiotechnologyProject ManagementRegulatory SubmissionsRegulatory Documentation- Regulatory Affairs Certification (RAC) — Regulatory Affairs Professionals Society (RAPS)
- Making Medicine | The Process of Drug Development — Eli Lilly and Company
From George's professional profile.
Colleagues at Intelligence Ventures
Frequently asked questions
- Where does George Gayed work?
- George Gayed is Associate at Intelligence Ventures.
Same school
Also attended Virginia Commonwealth University12
Nina MahmoudpourGeneral Counsel & Chief of Staff at Type One VenturesBruce SeidelDirector, Investments & Capital Allocation at eGateway CapitalJeremy CriderHead of Brand & Communications at SpeedinvestSteve WogenInvestor at HLM Investment PartnersRicco MendesVentures & Finance at StartUp HealthHeather MatrangaManaging Director, Impact Investments at Village Capital
+ 6 more
Shared employers
Also worked at Kite Pharma6
Peter EmtageVenture Partner at Versant VenturesArie BelldegrunFounder and Senior Managing Director at Vida VenturesJohn SmitherSenior Advisor at Frazier Life SciencesMarkwin VeldersAdvisory Committee member at Curie CapitalRaghav BhargavaPartner at PFM Health SciencesHelen KimPartner at The Column Group
